论文部分内容阅读
目的 探讨超声引导下经皮门静脉穿刺栓塞化疗的可行性。方法 对 2 0例原发性肝癌患者 ( 10例原发性肝癌合并门静脉癌栓 ) ,在HIFU及全身化疗的基础上进行治疗性门静脉栓塞化疗。结果 2 0例患者无 1例发生门静脉周围药物漏出、肝包膜下及腹腔内出血、穿刺后感染及气胸等并发症。结论 超声引导下经皮门静脉穿刺栓塞化疗是一种可行的治疗方法
Objective To investigate the feasibility of ultrasound-guided percutaneous portal vein embolization chemotherapy. Methods Twenty patients with primary liver cancer (10 cases of primary hepatocellular carcinoma with portal vein tumor thrombus) were treated with therapeutic portal vein chemoembolization on the basis of HIFU and systemic chemotherapy. Results None of the 20 patients had complications such as leakage of drugs around the portal vein, subretinal and intraperitoneal hemorrhage, post-puncture infection and pneumothorax. Conclusion Ultrasound-guided percutaneous portal vein embolization chemotherapy is a viable treatment